Medigene Presents Enhanced Tumor Cell Killing Effects upon
Planegg/Martinsried, 22 June 2023. Medigene AG (Medigene, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and...
Source: globenewswire.com
Stay updated with breaking news from Edigene Ag. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Planegg/Martinsried, 22 June 2023. Medigene AG (Medigene, FSE: MDG1, Prime Standard), an immuno-oncology platform company focusing on the discovery and...
Martinsried/Munich, March 16, 2023. Medigene AG (Medigene, FSE: MDG1, Prime Standard), an early stage immuno-oncology platform company focusing on the...